Turning Risk into Redundancy

Client is a top 3 Multi-National Pharmaceutical/Consumer/Healthcare Company. 

IPS built a state-of-the-art custom laboratory to support and expand client’s critical R&D and Stability operations during the COVID pandemic (2020). The IPS Laboratory was built in less than 90 days and fully functional in 6 months with new instrumentation sourced globally. The business model was a dedicated next-generation contract laboratory with full transparency and access to live data by the client. All data was stored on secure IPS servers on U.S. Soil. IPS prohibited any cloud-based operations to preserve data integrity and confidentiality. 

  • Challenges
  • IPS Solution

Critical capacity and utilization challenges:

  • All testing was performed in-house, with throughput constrained by limited instrument and analyst availability.  
  • No redundancy across critical operations, increasing risk and multiple points of failure.  
  • Inefficiencies driven by insufficient laboratory space and instrument capacity.  
  • Gaps in scientific expertise, unclear accountability, and inconsistent training standards. 

IPS delivered a fully functional dedicated Build-To-Suit R&D laboratory to provide:

  • Expanded functionality of Client Laboratories supporting R&D and associated stability functions. 
  • Direct data access and entry into Client ELN. 
  • Modular laboratory design for rapid retooling with space to expand. 
  • IPS pioneered automation processes to increase output and decrease analyst error. 
  • Introduction of new instrumentation to increase capabilities and eliminate antiquated techniques and methodologies. 
  • Developed new methods and implemented new technologies to modernize analytical capability and understanding. 
  • Full redundancy was established, eliminating R&D pipeline risk. 
  • All IPS Laboratory employees were established as SMEs on all the technologies from cross-training and continued to train client’s scientific staff. 
  • The IPS Laboratory Model proved a significant increase in efficiency and cost savings – resulting in an unparalleled increase in meaningful R&D while saving millions of dollars annually. 

 

All Success Stories